Table 1 |
|
|
Patient characteristics (n = 336) |
|
|
Age at diagnosis, years, median (IQR) |
62 (24-90) |
|
|
|
|
Overall survival, months, median (IQR) |
19.5 (0-271) |
|
|
|
|
FIGO Stage |
n (%) |
|
|
|
|
1 |
84 (25.0) |
|
|
|
|
2 |
36 (10.7) |
|
|
|
|
3 |
166 (49.4) |
|
|
|
|
4 |
40 (11.9) |
|
|
|
|
Missing |
10 (3.0) |
|
|
|
|
|
|
|
Grade |
n (%) |
|
|
|
|
G1 |
39 (11.6) |
|
|
|
|
G2 |
73 (21.7) |
|
|
|
|
G3 |
221 (65.8) |
|
|
|
|
Missing |
3 (0.9) |
|
|
|
|
|
|
|
Residual disease |
n (%) |
|
|
|
|
No macroscopic disease (Optimal debulking) |
128 (38.1) |
|
|
|
|
Macroscopic disease left |
194 (57.7) |
|
|
|
|
Missing |
14 (4.2) |
|
|
|
|
|
|
|
Histological type |
n (%) |
|
|
|
|
Serous |
178 (53) |
|
|
|
|
Mucinous |
35 (10.4) |
|
|
|
|
Endometriod |
42 (12.5) |
|
|
|
|
Clear cell |
25 (7.4) |
|
|
|
|
Undifferentiated |
54 (16.1) |
|
|
|
|
Missing |
2 (0.6) |
|
|
|
|
|
|
|
Chemotherapy |
n (%) |
|
|
|
|
Yes |
236 (70.2) |
|
|
|
|
No |
92 (27.4) |
|
|
|
|
Missing |
8 (2.4) |
|
|
|
|
|
|
|
Eag staining |
n (%) |
|
|
|
|
Low/Intermediate |
196 (58.3) |
|
|
|
|
High |
53 (15.8) |
|
|
|
|
Missing |
87 (25.9) |
|
|
|
|
|
|
|
HERG staining |
n (%) |
|
|
|
|
Low/Intermediate |
181 (53.9) |
|
|
|
|
High |
68 (20.2) |
|
|
|
|
Missing |
87 (25.9) |
|
|
|
|
Asher et al. Diagnostic Pathology 2010 5:78 doi:10.1186/1746-1596-5-78 |
|
